News : FDA: Safety board wants Cdn-led drug trial stopped - Heart Health - C-Health: " Drug giant Bayer Inc. confirmed Thursday that a large Canadian-led trial studying its drug Trasylol (aprotinin) has been halted because of concerns the drug increased the risk of death among people who received it. The U.S. Food and Drug Administration also posted a statement on the observed risk from the study, known as the BART trial, saying the agency will consider the new evidence as part of its ongoing deliberations on whether the drug should be removed from the market or have additional warnings on its label. "